deltatrials
Not Yet Recruiting OBSERVATIONAL NCT03127111

Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

The Identification, Validation and Implementation of Molecular Markers to Predict Response to Fluorouracil-based Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients - Prospective Clinical Observational Study

Sponsor: Renmin Hospital of Wuhan University

Conditions Stage III Colorectal Cancer
Interventions Gene expression analysis Gene methylation analysis Gene mutations analysis Protein expression analysis SNP analysis
Updated 15 times since 2017 Last updated: Mar 12, 2022 Started: Dec 1, 2022 Primary completion: Dec 31, 2025 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Stage III Colorectal Cancer, this trial is actively recruiting participants. The trial is conducted by Renmin Hospital of Wuhan University and has accumulated 15 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~May 2017 – ~Aug 2017 · 3 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Jun 2019 · 5 months · monthly snapshot~Jun 2019 – ~May 2020 · 11 months · monthly snapshot~May 2020 – ~Nov 2020 · 6 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Not Yet Recruiting

  2. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting

  3. Apr 2022 — Jul 2024 [monthly]

    Not Yet Recruiting

  4. Dec 2021 — Apr 2022 [monthly]

    Not Yet Recruiting

  5. Sep 2021 — Dec 2021 [monthly]

    Not Yet Recruiting

▶ Show 10 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Not Yet Recruiting

  2. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting

  3. May 2020 — Nov 2020 [monthly]

    Not Yet Recruiting

  4. Jun 2019 — May 2020 [monthly]

    Not Yet Recruiting

  5. Jan 2019 — Jun 2019 [monthly]

    Not Yet Recruiting

  6. Jun 2018 — Jan 2019 [monthly]

    Not Yet Recruiting

  7. May 2018 — Jun 2018 [monthly]

    Not Yet Recruiting

  8. Apr 2018 — May 2018 [monthly]

    Not Yet Recruiting

    Phase: NA → None

  9. Aug 2017 — Apr 2018 [monthly]

    Not Yet Recruiting NA

  10. May 2017 — Aug 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Renmin Hospital of Wuhan University
Data source: Renmin Hospital of Wuhan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations